Is It Too Late to Buy Longeveron Stock?

·4-min read
Is It Too Late to Buy Longeveron Stock?

Up nearly 400% in the last month alone, Longeveron (NASDAQ: LGVN) is doubtlessly one of the more volatile biotechs in the longevity space. Between its brief dalliance with meme stock traders in November and recent progress with regulatory authorities, plenty of people have made a lot of money on the stock. The key fact for investors to know about Longeveron is that it's a young biotech without any late-stage projects.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting